Hypoxia‐inducible factor prolyl hydroxylase inhibitor alleviates heatstroke‐induced acute kidney injury by activating BNIP3 ‐mediated mitophagy
The FASEB Journal · 30.06.2024 · 38 (12)
DOI: 10.1096/fj.202400047r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 12.06.2024. Verfasst von Ling Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Clinical Immunology, Daping Hospital, Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Heat Stroke, Membrane Proteins, Mitophagy. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Daping Hospital, Army Medical University, talent innovation ability training program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Hypoxia‐induced inflammation and apoptosis are important pathophysiological features of heat stroke‐induced acute kidney injury (HS‐AKI). Hypoxia‐inducible factor (HIF) is a key protein that regulates cell adaptation to hypoxia. HIF‐prolyl hydroxylase inhibitor (HIF‐PHI) stabilizes HIF to increase cell adaptation to hypoxia. Herein, we reported that HIF‐PHI pretreatment significantly improved renal function, enhanced thermotolerance, and increased the survival rate of mice in the context of HS. Moreover, HIF‐PHI could alleviate HS‐induced mitochondrial damage, inflammation, and apoptosis in renal tubular epithelial cells (RTECs) by enhancing mitophagy in vitro and in vivo. By contrast, mitophagy inhibitors Mdivi‐1, 3‐MA, and Baf‐A1 reversed the renoprotective effects of HIF‐PHI. Mechanistically, HIF‐PHI protects RTECs from inflammation and apoptosis by enhancing Bcl‐2 adenovirus E18 19‐kDa–interacting protein 3 ( BNIP3 )‐mediated mitophagy, while genetic ablation of BNIP3 attenuated HIF‐PHI‐induced mitophagy and abolished HIF‐PHI‐mediated renal protection. Thus, our results indicated that HIF‐PHI protects renal function by upregulating BNIP3 ‐mediated mitophagy to improve HS‐induced inflammation and apoptosis of RTECs, suggesting HIF‐PHI as a promising therapeutic agent to treat HS‐AKI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Clinical Immunology, Daping Hospital, Army Medical University, Chongqing, China.
- Department of Tropical Medicine, Army Medical University, Chongqing, China.
- Key Laboratory of Extreme Environmental Medicine, Ministry of Education of China, Army Medical University, Chongqing, China.
ORCID-Profile: Ling Wang, Yongwei Song, Pan Zhang, Wenting Chen, Fei Xiao, Ping Zhou, Xuesen Yang, Huanzi Dai
Förderung
- Daping Hospital, Army Medical University, talent innovation ability training program
- National Natural Science Foundation of China
Zitieren
APA
Wang, L., Song, Y., Zhang, P., Chen, W., Xiao, F., Zhou, P., Yang, X., & Dai, H. (2024). Hypoxia‐inducible factor prolyl hydroxylase inhibitor alleviates heatstroke‐induced acute kidney injury by activating BNIP3 ‐mediated mitophagy. The FASEB Journal, 38(12). https://doi.org/10.1096/fj.202400047r
Vancouver
Wang L, Song Y, Zhang P, Chen W, Xiao F, Zhou P, et al. Hypoxia‐inducible factor prolyl hydroxylase inhibitor alleviates heatstroke‐induced acute kidney injury by activating BNIP3 ‐mediated mitophagy. The FASEB Journal. 2024;38(12). doi:10.1096/fj.202400047r
BibTeX
@article{Wang2024,
author = {Wang, Ling and Song, Yongwei and Zhang, Pan and Chen, Wenting and Xiao, Fei and Zhou, Ping and Yang, Xuesen and Dai, Huanzi},
title = {Hypoxia‐inducible factor prolyl hydroxylase inhibitor alleviates heatstroke‐induced acute kidney injury by activating BNIP3 ‐mediated mitophagy},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {12},
doi = {10.1096/fj.202400047r}
}
EUVIMED